Bal Pharma Ltd. | Small-cap | Healthcare
₹99.94
-0.10%
| Bal Pharma Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 3.0B
Gross Profit 1.5B 47.90%
Operating Income 197.9M 6.53%
Net Income 72.4M 2.39%
EPS (Diluted) ₹4.56

Balance Sheet Metrics

Total Assets 3.4B
Total Liabilities 2.6B
Shareholders Equity 774.0M
Debt to Equity 3.34

Cash Flow Metrics

Operating Cash Flow 74.6M
Free Cash Flow 15.3M

Revenue & Profitability Trend

Bal Pharma Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 3.0B 3.3B 3.0B 2.8B 2.5B
Cost of Goods Sold 1.6B 2.0B 1.8B 1.7B 1.5B
Gross Profit 1.5B 1.3B 1.3B 1.1B 942.3M
Operating Expenses 532.3M 499.6M 447.9M 405.8M 286.4M
Operating Income 197.9M 225.5M 175.4M 150.6M 170.9M
Pre-tax Income 51.4M 90.5M 47.5M 91.8M 41.0M
Income Tax -21.0M 16.0M 21.3M 34.8M -6.1M
Net Income 72.4M 74.5M 26.2M 57.0M 47.1M
EPS (Diluted) ₹4.56 ₹4.94 ₹1.67 ₹3.79 ₹3.34

Income Statement Trend

Bal Pharma Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 2.3B 2.3B 2.3B 1.8B 1.6B
Non-Current Assets 1.0B 853.8M 850.2M 759.6M 759.3M
Total Assets 3.4B 3.2B 3.1B 2.6B 2.4B
Liabilities
Current Liabilities 2.2B 2.0B 2.1B 1.7B 1.5B
Non-Current Liabilities 387.9M 472.2M 401.4M 364.0M 341.9M
Total Liabilities 2.6B 2.5B 2.5B 2.0B 1.9B
Equity
Total Shareholders Equity 774.0M 692.6M 637.0M 584.9M 533.5M

Balance Sheet Composition

Bal Pharma Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 51.4M 90.5M 47.5M 91.8M 41.0M
Operating Cash Flow 74.6M 192.9M -386.1M -27.8M 18.0M
Investing Activities
Capital Expenditures -187.9M -109.7M -146.5M -84.7M -33.6M
Investing Cash Flow -187.9M -109.7M -146.5M -84.7M -43.2M
Financing Activities
Dividends Paid -19.1M -15.7M -15.6M -14.8M -
Financing Cash Flow 90.1M 151.2M 382.6M -68.2M -10.3M
Free Cash Flow 15.3M 118.3M -161.8M 183.3M 189.7M

Cash Flow Trend

Bal Pharma Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 21.72
Price to Book 2.53
Price to Sales 0.52
PEG Ratio -2.82

Profitability Ratios

Profit Margin 2.38%
Operating Margin 6.67%
Return on Equity 9.87%
Return on Assets 3.78%

Financial Health

Current Ratio 1.07
Debt to Equity 194.32
Beta 0.20

Per Share Data

EPS (TTM) ₹4.56
Book Value per Share ₹39.09
Revenue per Share ₹191.55

Financial data is updated regularly. All figures are in the company's reporting currency.